研究文章
SOX2的效用和AGR2生物标志物的早期预测三苯氧胺耐药性雌激素受体阳性乳腺癌患者
|
|
组1 (n= 124) |
组2 (n= 48) |
组3 (n= 52) |
团体的考验。 |
|
|
| 年龄(年) |
|
|
|
|
|
| 平均数±标准差 |
51.4±12.7 |
59.9±10 |
59.5±12.3 |
F= 12.899 |
< 0.001 |
| 中位数(min.-max)。 |
48 (28 - 77) |
63.5 (39 - 77) |
64 (36 - 78) |
| 组织学类型 |
|
|
|
|
|
| 浸润小叶CA |
16 (12.9%) |
3 (6.3%) |
9 (17.3%) |
χ2 = 2.832 |
0.243 |
| 浸润导管CA |
108例(87.1%) |
45 (93.8%) |
43 (82.7%) |
| 病态的T台 |
|
|
|
|
|
| T1 |
78例(62.9%) |
2 (4.2%) |
32 (61.5%) |
χ2= 132.671 |
< 0.001 |
| T2 |
33 (26.6%) |
12 (25.0%) |
16 (30.8%) |
| T3 |
13 (10.5%) |
5 (10.4%) |
4 (7.7%) |
| T4 |
0 (0.0%) |
29 (60.4%) |
0 (0.0%) |
| 病理N阶段 |
|
|
|
|
|
| N0 |
93例(75.0%) |
2 (4.2%) |
35 (67.3%) |
χ2= 80.737 |
< 0.001 |
| N1 |
24 (19.4%) |
27 (56.3%) |
14 (26.9%) |
| N2 |
7 (5.6%) |
19 (39.6%) |
3 (5.8%) |
| 年级 |
|
|
|
|
|
| 我 |
37 (29.8%) |
2 (4.2%) |
14 (26.9%) |
χ2= 17.005 |
0.002 |
| 二世 |
64例(51.6%) |
40 (83.3%) |
28 (53.8%) |
| 三世 |
23 (18.5%) |
6 (12.5%) |
10 (19.2%) |
| 淋巴血管侵犯 |
|
|
|
|
|
| 没有 |
75例(60.5%) |
10 (20.8%) |
25 (48.1%) |
χ2= 21.797 |
< 0.001 |
| 是的 |
49 (39.5%) |
38 (79.2%) |
27 (51.9%) |
| 绝经情况 |
|
|
|
|
|
| 前 |
61例(49.2%) |
11 (22.9%) |
13 (25.0%) |
χ2= 14.968 |
0.001 |
| 帖子 |
63例(50.8%) |
37 (77.1%) |
39 (75.0%) |
| 类型的阻力 |
|
|
|
|
|
| 新创 |
- - - - - - |
15 (31.3%) |
0 (0.0%) |
χ2= 19.118 |
< 0.001 |
| 收购了 |
- - - - - - |
33 (68.8%) |
52 (100.0%) |
| 演讲失败 |
|
|
|
|
|
| 远处转移 |
- - - - - - |
- - - - - - |
11 (21.2%) |
− |
- - - - - - |
| 递归式 |
- - - - - - |
- - - - - - |
41 (78.8%) |
| 时间它莫西芬失败 |
|
|
|
|
|
| 平均数±标准差。 |
- - - - - - |
13.4±6.8 |
23.1±6.2 |
U= 373.50 |
< 0.001 |
| 中值(最小-最大)。 |
- - - - - - |
16 (2-24) |
23日(14-44) |
|
|
χ
2:卡方检验。F: F方差分析测试,两两比较选择。每个使用事后做了两组测试(图基),U: Mann-Whitney测试,
:
值之间的比较研究团体, 重要的组1和 统计学意义的
。
|
